Advertisement

April 19, 2014

FDA Issues Proposed Rule on cGMPs for Food to Implement Parts of Food Safety Modernization Act

On the two year anniversary of the adoption of the Food Safety Modernization Act (FSMA or Act), the FDA recently issued a lengthy proposed rule to update its existing rules on current Good Manufacturing Practices for food. At the same time, the FDA issued a separate proposed rule covering standards for produce safety (which is the subject of a contemporaneous Alert) and stated that it expects to release soon rules on foreign supplier verification required by the FSMA.

The proposed update to current Good Manufacturing Practices for foods will apply generally to any food facility that is required to register with the FDA. The rule does propose clarifications to the definition of “facility” and the exemption for “farms” to require compliance with the proposed rule by farms that conduct activities that require registration, such as on-farm manufacturing or processing of food not consumed on the farm.

Perhaps the highlight of the proposed rule is a proposed new Part 117, Subpart C, to 21 C.F.R. adopting requirements for hazard analysis and risk-based preventive controls. Some of the key components of these requirements include:

  • A written hazard analysis identifying and evaluating known or reasonably foreseeable for each type of food manufactured, process, packed or held in the facility
  • Written and implemented preventive controls, including process, food allergen, and sanitation controls, to assure that any hazards that are reasonably likely to occur are prevented or at least significantly minimized so that food at the facility will not be adulterated
  • A written recall plan covering at least foods with hazards that are reasonably likely to occur
  • Monitoring the preventive controls to provide assurance that they are consistently performed, and documenting the implementation of the monitoring procedures
  • Written corrective actions to be taken in case the preventive controls are not performed or in the event of an unanticipated problem
  • Verification activities, including validation of at least a subset of the preventive controls, verification that the preventive controls are consistently implemented and effective, and verification of appropriate decisions on corrective actions
  • A re-analysis of the food safety plan at least every three years
  • A “qualified individual” – by experience or completing a standard curriculum – must oversee all of the above activities
  • Records for all of the above activities, including the training of the qualified individual

The proposed rule includes revisions to 21 C.F.R. Part 110 on Good Manufacturing Practices for food, including provisions to clarify that protection against contamination requires protection against cross-contact of foods to address allergens and to extend contamination protection to food packaging materials. This portion also deletes certain recommendations, including those directed to specific temperatures for maintaining frozen, refrigerated, or hot foods. The content is re-located to Part 117, Subpart B.

Proposed Part 117, Subpart D, addresses the requirements for a “qualified facility” and requirements to submit various types of documents to FDA to establish such status.

Proposed Part 117, Subpart E, establishes the conditions and procedures for withdrawing an exemption given to a qualified facility.

Proposed Part 117, Subpart F, includes records requirements related to the other sections of Part 117, including retention requirements.

The proposed rule also includes several exemptions. The FDA provided a 120 day period for the public to comment on the rule, and will publish a final version at some point thereafter. Although the rule will be effective 60 days after the FDA adopts the final version, the FDA will generally give businesses one year from the publication of the final rule to comply, small businesses two years, and very small businesses three years.

A copy of the FDA’s proposed rule on cGMPs for food can be found here.

© 2014 BARNES & THORNBURG LLP

About the Author

Barnes & Thornburg's Food, Drug & Device Law practice group helps pharmaceutical, biotechnology, medical device, diagnostic, food, dietary supplement and cosmetic companies, as well as other healthcare entities, throughout the product lifecycle, from concept, development and approval to manufacturing, marketing, ongoing compliance, investigation, enforcement actions and litigation. We advise clients on the ever-evolving laws and FDA regulations that govern their products and components. Moreover, we have the government experience and industry knowledge necessary to...

317-231-7511

Boost: AJAX core statistics

Legal Disclaimer

You are responsible for reading, understanding and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's  Terms of Use and Privacy Policy before using the National Law Review website. The National Law Review is a free to use, no-log in database of legal and business articles. The content and links on www.NatLawReview.com are intended for general information purposes only. Any legal analysis, legislative updates or other content and links should not be construed as legal or professional advice or a substitute for such advice. No attorney-client or confidential relationship is formed by the transmission of information between you and the National Law Review website or any of the law firms, attorneys or other professionals or organizations who include content on the National Law Review website. If you require legal or professional advice, kindly contact an attorney or other suitable professional advisor.  

Some states have laws and ethical rules regarding solicitation and advertisement practices by attorneys and/or other professionals. The National Law Review is not a law firm nor is www.NatLawReview.com  intended to be  a referral service for attorneys and/or other professionals. The NLR does not wish, nor does it intend, to solicit the business of anyone or to refer anyone to an attorney or other professional.  NLR does not answer legal questions nor will we refer you to an attorney or other professional if you request such information from us. 

Under certain state laws the following statements may be required on this website and we have included them in order to be in full compliance with these rules. The choice of a lawyer or other professional is an important decision and should not be based solely upon advertisements. Attorney Advertising Notice: Prior results do not guarantee a similar outcome. Statement in compliance with Texas Rules of Professional Conduct. Unless otherwise noted, attorneys are not certified by the Texas Board of Legal Specialization, nor can NLR attest to the accuracy of any notation of Legal Specialization or other Professional Credentials.

The National Law Review - National Law Forum LLC 4700 Gilbert Ave. Suite 47 #230 Western Springs, IL 60558  Telephone  (708) 357-3317 If you would ike to contact us via email please click here.